Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Global Pharm acquires Shandong distributor as consolidation trend ramps

This article was originally published in Scrip

Executive Summary

The Chinese pharmaceutical distributor Global Pharm Holdings Group has acquired 100% of Qingdao Likang Pharmaceutical, a regional distributor in the country, for $1.6 million in cash in a bid to expand its network in Shandong province.

You may also be interested in...

FDA nod for first 'made in China' MAb

China is known for a global supplier of active pharmaceutical ingredients, but with continuous investment in advanced facilities and talents, it is likely to be a global supplier of biological therapies. The US approval of a 'made in China' monoclonal antibody for use in clinical trials marks a milestone in China's journey.

Fosun licenses novel TB treatment for China

Shanghai-based, Hong Kong and Shanghai listed Fosun Pharmaceutical has been busy adding foreign assets under its belt.

China's state council demands raised quality for "essential drugs"

Officials at the highest level of China's government have said that the quality of medicines on China's essential drugs list must be raised to international standards, a move that challenges the existing essential drugs scheme in the country1.





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts